$20.62 +$0.35 (+1.73%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $20.57 -0.24%
开盘$20.14
昨收$20.27
当日区间$19.41 – $20.80
成交量1.85M
市值$1.19B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$94.50M+19.3% YoY
营业利润-$27.39M-23.4% YoY
净利润-$26.86M-37.2% YoY
摊薄每股收益-$0.47-34.3% YoY
自由现金流-$22.20M-24.4% YoY
经营现金流-$19.25M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率64.2%
营业利润率-33.9%
净利率-32.5%
净资产收益率-30.2%
资产收益率-22.1%
投入资本回报率-25.5%
流动比率6.55
负债/资产比率29.1%
现金及投资$227.91M
总负债$75.00M
净现金（净负债）$152.92M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $94.50M | $83.13M | $308.05M | $76.38M | $83.33M |
| 营业总收入 | $94.50M | $83.13M | $308.05M | $76.38M | $83.33M |
| 营业成本 | $32.12M | $29.19M | $111.83M | $30.07M | $29.32M |
| 毛利润 | $62.38M | $53.95M | $196.23M | $46.31M | $54.01M |
| 营业费用 | $89.77M | $86.55M | $300.09M | $77.35M | $77.20M |
| 销售及管理费用 | $69.67M | $65.09M | $228.81M | $58.30M | $59.01M |
| 研发费用 | $20.10M | $21.47M | $71.28M | $19.06M | $18.19M |
| 营业利润 | -$27.39M | -$32.61M | -$103.86M | -$31.04M | -$23.19M |
| 非经营性利息净收入（支出） | $623,000.00 | $925,000.00 | $8.63M | $1.54M | $1.78M |
| 非经营性利息收入 | $1.47M | $1.74M | $12.22M | $2.44M | $2.70M |
| 非经营性利息支出 | $842,000.00 | $818,000.00 | $3.59M | $894,000.00 | $919,000.00 |
| 税前利润 | -$26.77M | -$31.68M | -$95.38M | -$29.66M | -$21.41M |
| 税费 | $94,000.00 | -$43,000.00 | $190,000.00 | – | – |
| 净利润 | -$26.86M | -$31.64M | -$95.57M | -$29.85M | -$21.41M |
| 持续经营利润 | -$26.86M | -$31.64M | -$95.57M | -$29.85M | -$21.41M |
| 归属母公司净利润 | -$26.86M | -$31.64M | -$95.57M | -$29.85M | -$21.41M |
| 归属普通股股东净利润 | -$26.86M | -$31.64M | -$95.57M | -$29.85M | -$21.41M |
| 基本每股收益 | -$0.47 | -$0.56 | -$1.72 | -$0.53 | -$0.38 |
| 摊薄每股收益 | -$0.47 | -$0.56 | -$1.72 | -$0.53 | -$0.38 |
| 其他收入（支出） | – | – | -$156,000.00 | – | – |
| 其他非经营性收入（支出） | – | – | -$156,000.00 | – | – |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $479.35M | $487.06M | $508.08M | $508.08M | $511.54M |
| 流动资产合计 | $420.29M | $428.03M | $450.38M | $450.38M | $454.75M |
| 现金及现金等价物与短期投资 | $227.91M | $245.64M | $286.50M | $286.50M | $294.28M |
| -现金及现金等价物 | $227.91M | $245.64M | $286.50M | $286.50M | $294.28M |
| 应收款 | $107.61M | $96.39M | $83.53M | $83.53M | $84.50M |
| -应收账款 | $107.61M | $96.39M | $83.53M | $83.53M | $84.50M |
| 存货 | $77.06M | $77.54M | $70.69M | $70.69M | $66.72M |
| 其他流动资产 | $7.70M | $8.47M | $9.65M | $9.65M | $9.25M |
| 非流动资产合计 | $59.07M | $59.03M | $57.70M | $57.70M | $56.79M |
| 固定资产净值 | $48.61M | $48.90M | $47.94M | $47.94M | $47.93M |
| -固定资产原值 | $64.94M | $63.32M | $60.69M | $60.69M | $60.12M |
| -累计折旧 | -$16.34M | -$14.42M | -$12.75M | -$12.75M | -$12.20M |
| 商誉及其他无形资产 | $571,000.00 | $640,000.00 | $709,000.00 | $709,000.00 | $727,000.00 |
| 其他非流动资产 | $9.89M | $9.49M | $9.06M | $9.06M | $8.14M |
| 负债合计 | $139.28M | $139.40M | $142.21M | $142.21M | $131.27M |
| 流动负债合计 | $64.20M | $63.64M | $65.80M | $65.80M | $53.90M |
| 应付款 | $15.07M | $18.85M | $18.74M | $18.74M | $11.12M |
| -应付账款 | $15.07M | $18.85M | $17.29M | $17.29M | $11.12M |
| 短期债务及融资租赁负债 | $2.51M | $2.36M | $2.21M | $2.21M | $2.14M |
| -一年内到期融资租赁负债 | $2.51M | $2.36M | $2.21M | $2.21M | $2.14M |
| 一年内递延负债 | $14.09M | $13.70M | $13.05M | $13.05M | $10.67M |
| 其他流动负债 | $12.09M | $10.25M | $7.39M | $7.39M | $8.18M |
| 非流动负债合计 | $75.09M | $75.76M | $76.42M | $76.42M | $77.37M |
| 长期债务及融资租赁负债 | $75.00M | $75.64M | $76.27M | $76.27M | $76.79M |
| -长期债务 | $51.72M | $51.66M | $51.62M | $51.62M | $51.57M |
| -长期融资租赁负债 | $23.28M | $23.97M | $24.65M | $24.65M | $25.23M |
| 其他非流动负债 | $91,000.00 | $121,000.00 | $147,000.00 | $147,000.00 | $576,000.00 |
| 股东权益合计 | $340.07M | $347.67M | $365.87M | $365.87M | $380.28M |
| 股东权益 | $340.07M | $347.67M | $365.87M | $365.87M | $380.28M |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $1.04B | $1.02B | $1.01B | $1.01B | $991.95M |
| 留存收益 | -$700.06M | -$673.20M | -$641.56M | -$641.56M | -$611.71M |
| 不影响留存收益的损益 | $22,000.00 | -$19,000.00 | $37,000.00 | $37,000.00 | $42,000.00 |
| -其他无形资产 | – | – | $709,000.00 | $709,000.00 | – |
| -应付税款合计 | – | – | $1.46M | $1.46M | – |
| 一年内应计费用 | – | – | $1.23M | $1.23M | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$19.25M | -$38.13M | -$48.99M | -$10.33M | -$6.64M |
| 持续经营经营活动现金流净额 | -$19.25M | -$38.13M | -$48.99M | -$10.33M | -$6.64M |
| 持续经营净利润 | -$26.86M | -$31.64M | -$95.57M | -$29.85M | -$21.41M |
| 持续经营损益 | $134,000.00 | $297,000.00 | $157,000.00 | $278,000.00 | $227,000.00 |
| 折旧、折耗与摊销 | $1.99M | $1.74M | $6.39M | $1.71M | $1.62M |
| 其他非现金项目 | -$159,000.00 | -$159,000.00 | -$508,000.00 | -$127,000.00 | -$127,000.00 |
| 营运资金变动 | -$9.73M | -$21.90M | -$7.84M | $8.02M | -$2.03M |
| -应收款变动 | -$11.63M | -$13.32M | -$898,000.00 | $2.23M | -$4.35M |
| -存货变动 | $199,000.00 | -$7.03M | -$14.50M | -$4.00M | $568,000.00 |
| -预付资产变动 | $799,000.00 | $1.17M | -$1.10M | -$431,000.00 | -$1.76M |
| -应付账款及应计费用变动 | -$839,000.00 | -$3.10M | $8.38M | $7.36M | $4.71M |
| -其他流动资产变动 | -$404,000.00 | -$431,000.00 | -$2.90M | -$922,000.00 | -$808,000.00 |
| -其他流动负债变动 | $1.79M | $180,000.00 | -$132,000.00 | $1.83M | -$1.52M |
| -其他营运资金变动 | $356,000.00 | $628,000.00 | $3.31M | $1.95M | $1.13M |
| 投资活动现金流净额 | -$2.95M | -$2.91M | -$9.36M | -$1.85M | -$2.87M |
| 持续经营投资活动现金流净额 | -$2.95M | -$2.91M | -$9.36M | -$1.85M | -$2.87M |
| 固定资产购置及出售净额 | -$2.95M | -$2.91M | -$9.36M | -$1.85M | -$2.87M |
| 筹资活动现金流 | $4.50M | $222,000.00 | $11.19M | $4.44M | $1.08M |
| 持续经营筹资活动现金流净额 | $4.50M | $222,000.00 | $11.19M | $4.44M | $1.08M |
| 股票期权行使所得 | $4.50M | $222,000.00 | $11.19M | $4.44M | $1.08M |
| 期末现金余额 | $230.95M | $248.68M | $289.54M | $289.54M | $297.32M |
| 现金净变动 | -$17.71M | -$40.82M | -$47.15M | -$7.74M | -$8.43M |
| 期初现金余额 | $248.68M | $289.54M | $336.76M | $297.32M | $305.76M |
| 汇率变动影响 | -$20,000.00 | -$42,000.00 | -$74,000.00 | -$41,000.00 | -$10,000.00 |
| 自由现金流 | -$22.20M | -$41.04M | -$58.34M | -$12.18M | -$9.50M |
| 普通股发行净额 | – | – | $0.00 | – | – |
暂无评论——快来第一个聊聊 PRCT。